Reaction
Autoimmune Hypothyroidism reporting signals
As of the last recalculation, Autoimmune Hypothyroidism appears in 231 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 118.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 23 | 118.9 | 119.0 |
| Pembrolizumab | 82 | 108.3 | 108.4 |
| Ipilimumab | 21 | 48.1 | 48.1 |
| Nivolumab | 38 | 42.2 | 42.2 |
| Durvalumab | 9 | 41.4 | 41.5 |
| Pemetrexed | 8 | 34.8 | 34.8 |
| Atezolizumab | 11 | 26.7 | 26.8 |